Biocon secures Yesintek biosimilar rights in nine markets EP News Bureau Oct 26, 2026 The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil,…
Bio-Thera, Dr. Reddy’s partner to commercialise BAT2206, a proposed Stelara Biosimilar, and BAT2506,… EP News Bureau Mar 28, 2025 Under the agreement, Bio-Thera will develop, manufacture, and supply BAT2206 and BAT2506. Dr. Reddy’s will seek regulatory…
